Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ruof

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Rheumatology International|November 2, 2005
Costs in rheumatology: results and lessons learned from the 'Hannover Costing Study'J L Hülsemann, J Ruof, H Zeidler, et al.
Zeitschrift Fur Rheumatologie|November 23, 2013
[Phase IV non-interventional studies in the treatment of rheumatoid arthritis with biologicals in Germany : real-life clinical practice data]J Ruof, C Iking-Konert, S Simianer, et al.
Zeitschrift Fur Rheumatologie|April 27, 2002
[Health economics research in the area of chronic polyarthritis]S Merkesdal, J Ruof, T Mittendorf, et al.
International Journal of Obesity (2005)|April 27, 2005
Cost-effectiveness of orlistat for the treatment of overweight and obese patients in IrelandL A Lacey, A Wolf, D O'shea, et al.
Arthritis and Rheumatism|March 27, 2001
Indirect medical costs in early rheumatoid arthritis: composition of and changes in indirect costs within the first three years of diseaseS Merkesdal, J Ruof, O Schöffski, et al.
International Journal of Obesity (2005)|March 2, 2005
Orlistat in responding obese type 2 diabetic patients: meta-analysis findings and cost-effectiveness as rationales for reimbursement in Sweden and SwitzerlandJ Ruof, A Golay, C Berne, et al.
Pharmacopsychiatry|July 4, 2001
Quality of partnership in patients with erectile dysfunction after sildenafil treatmentM J Müller, J Ruof, M Graf-Morgenstern, et al.
International Journal of Obesity (2005)|April 6, 2006
Content comparison of health status measures for obesity based on the international classification of functioning, disability and healthA Stucki, M Borchers, G Stucki, et al.
MMW Fortschritte Der Medizin|September 28, 2000
[Guidelines for lowering lipids are too infrequently observed. Results of a retrospective study of coronary heart disease patients]G Klein, J Ruof, W März, et al.
Preventive Medicine|June 25, 2002
Lipid-lowering medication for secondary prevention of coronary heart disease in a German outpatient population: the gap between treatment guidelines and real life treatment patternsJ Ruof, G Klein, W März, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Rheumatology International|November 2, 2005
Costs in rheumatology: results and lessons learned from the 'Hannover Costing Study'J L Hülsemann, J Ruof, H Zeidler, et al.
Zeitschrift Fur Rheumatologie|November 23, 2013
[Phase IV non-interventional studies in the treatment of rheumatoid arthritis with biologicals in Germany : real-life clinical practice data]J Ruof, C Iking-Konert, S Simianer, et al.
Zeitschrift Fur Rheumatologie|April 27, 2002
[Health economics research in the area of chronic polyarthritis]S Merkesdal, J Ruof, T Mittendorf, et al.
International Journal of Obesity (2005)|April 27, 2005
Cost-effectiveness of orlistat for the treatment of overweight and obese patients in IrelandL A Lacey, A Wolf, D O'shea, et al.
Arthritis and Rheumatism|March 27, 2001
Indirect medical costs in early rheumatoid arthritis: composition of and changes in indirect costs within the first three years of diseaseS Merkesdal, J Ruof, O Schöffski, et al.
International Journal of Obesity (2005)|March 2, 2005
Orlistat in responding obese type 2 diabetic patients: meta-analysis findings and cost-effectiveness as rationales for reimbursement in Sweden and SwitzerlandJ Ruof, A Golay, C Berne, et al.
Pharmacopsychiatry|July 4, 2001
Quality of partnership in patients with erectile dysfunction after sildenafil treatmentM J Müller, J Ruof, M Graf-Morgenstern, et al.
International Journal of Obesity (2005)|April 6, 2006
Content comparison of health status measures for obesity based on the international classification of functioning, disability and healthA Stucki, M Borchers, G Stucki, et al.
MMW Fortschritte Der Medizin|September 28, 2000
[Guidelines for lowering lipids are too infrequently observed. Results of a retrospective study of coronary heart disease patients]G Klein, J Ruof, W März, et al.
Preventive Medicine|June 25, 2002
Lipid-lowering medication for secondary prevention of coronary heart disease in a German outpatient population: the gap between treatment guidelines and real life treatment patternsJ Ruof, G Klein, W März, et al.
Pageof 3